Ignet

Gene Information

Gene symbol: CD300C

Gene name: CD300c molecule

HGNC ID: 19320

Synonyms: CMRF35, LIR, CMRF-35A, CMRF35A, IGSF16

Related Genes

#	Gene Symbol	Number of hits
1	CD300A	1 hits
2	CD4	1 hits
3	CD8A	1 hits
4	IFNG	1 hits

Related Sentences

#	PMID	Sentence
1	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
2	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
3	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
4	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
5	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
6	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
7	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
8	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
9	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
10	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
11	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
12	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
13	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
14	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
15	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
16	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
17	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
18	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
19	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
20	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
21	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
22	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
23	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
24	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
25	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
26	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
27	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
28	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
29	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
30	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
31	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
32	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
33	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
34	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
35	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
36	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
37	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
38	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
39	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
40	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
41	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
42	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
43	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
44	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
45	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
46	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
47	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
48	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
49	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
50	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
51	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
52	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
53	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
54	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
55	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
56	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
57	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
58	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
59	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
60	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
61	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
62	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
63	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
64	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
65	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
66	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
67	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
68	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
69	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
70	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
71	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
72	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
73	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
74	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
75	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
76	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
77	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
78	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
79	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
80	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
81	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
82	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
83	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
84	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
85	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
86	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
87	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
88	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
89	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
90	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
91	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
92	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
93	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
94	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
95	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
96	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
97	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
98	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
99	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
100	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
101	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
102	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
103	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
104	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
105	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
106	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
107	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
108	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
109	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
110	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
111	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
112	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
113	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
114	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
115	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
116	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
117	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
118	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
119	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
120	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
121	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
122	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
123	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
124	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
125	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
126	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
127	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
128	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
129	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
130	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
131	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
132	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
133	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
134	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
135	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
136	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
137	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
138	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
139	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
140	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
141	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
142	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
143	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.
144	17702825	Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression.
145	17702825	The CD300c (CMRF-35A) and CD300a (CMRF-35H) molecules are leukocyte surface proteins that are part of a larger family of immunoregulatory molecules encoded by a gene complex on human chromosome 17.
146	17702825	The CMRF-35 monoclonal antibody binds to an epitope common to both molecules, expressed on most human leukocyte populations, apart from B lymphocytes and a subpopulation of CD4(+) and CD8(+) T lymphocytes.
147	17702825	We describe the CMRF-35(pos) and CMRF-35(-) fractions of CD4(+) T lymphocytes.
148	17702825	The CMRF-35(pos) fraction can further be divided into CMRF-35(++) and CMRF-35(+)CD4(+) T lymphocyte subpopulations.
149	17702825	Resting peripheral CD4(+) T lymphocytes express CD300a mRNA and very low amounts of CD300c.
150	17702825	Activation results in an initial decrease in CD300a gene expression before an increase in both CD300a and CD300c gene expression.
151	17702825	The CMRF-35(-) fraction of CD4(+) T lymphocytes proliferated to a greater extent than the CMRF-35(pos) fraction, in response to mitogens or allogeneic antigen.
152	17702825	The poor proliferation of the CMRF-35(pos) CD4(+) in response to mitogens was explained by increased apoptosis within this subpopulation.
153	17702825	The recall antigen, tetanus toxoid, stimulated the CMRF-35(++)CD4(+)CD45RO(+) but not the CMRF-35(-)CD4(+)CD45RO(+) subpopulation.
154	17702825	Resting CMRF-35(++) CD4(+) lymphocytes express low levels of IFN-gamma mRNA.
155	17702825	Within 18 h following in vitro activation, CMRF-35(++) CD4(+) lymphocytes express more IFN-gamma mRNA and protein compared with the CMRF-35(-)CD4(+) lymphocytes, however, after 24 h, both the CMRF-35(+) and CMRF-35(-)CD4(+) T lymphocytes were able to produce IFN-gamma.
156	17702825	The CMRF-35(++)CD4(+) T lymphocyte population contains the Th(1) memory effector cells.